These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7809452)

  • 1. [Hyperlipoproteinemia in the production of atherosclerosis. Risk factors: diagnosis and treatment].
    Pedraza A
    Rev Fac Cien Med Univ Nac Cordoba; 1993; 51(1):21-33. PubMed ID: 7809452
    [No Abstract]   [Full Text] [Related]  

  • 2. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
    Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
    Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arteriosclerosis without risk factors?].
    Windler E
    Dtsch Med Wochenschr; 1990 Apr; 115(16):636-7. PubMed ID: 2328671
    [No Abstract]   [Full Text] [Related]  

  • 6. Can genes prevent atherosclerosis?
    Hoeg JM
    JAMA; 1996 Sep; 276(12):989-92. PubMed ID: 8805735
    [No Abstract]   [Full Text] [Related]  

  • 7. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hyperlipoproteinemia by plasma exchange].
    Homma Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():370-3. PubMed ID: 1578709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of insulin therapy on lipoprotein concentrations in secondary sulfonylurea treatment failures in menopause].
    Schauer UJ
    Z Gesamte Inn Med; 1988 Dec; 43(23):666-9. PubMed ID: 3149825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A favorable hyperlipoproteinemia: high-density lipoproteins and atherosclerosis].
    James RW; Borghini I
    Ther Umsch; 1990 Jun; 47(6):448-55. PubMed ID: 2197754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the serum lipids in workers of lead industry].
    Gatagonova TM
    Med Tr Prom Ekol; 1994; (12):17-21. PubMed ID: 7719652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is hypolipemic treatment effective as a preventive measure?].
    Rywik S
    Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917
    [No Abstract]   [Full Text] [Related]  

  • 15. [New prospects in the study of the relations between hypertension and atherosclerosis].
    Eliseev OM
    Ter Arkh; 1994; 66(4):71-6. PubMed ID: 8016737
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
    Gajdos M; Fedelesova V; Mongiellova V; Cibulova L; Huttova D; Polak F; Krivosikova Z
    Bratisl Lek Listy; 1999 Aug; 100(8):449-53. PubMed ID: 10645034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic cause of unstable atherosclerotic plaques.
    Violi F; Loffredo L
    Lancet; 2000 Apr; 355(9212):1362; author reply 1363-4. PubMed ID: 10776764
    [No Abstract]   [Full Text] [Related]  

  • 19. [HDL-cholesterol and LDL-cholesterol in younger and older obese patients and the relation to atherogenesis].
    Felt V
    Cas Lek Cesk; 1987 Aug; 126(32):1013-5. PubMed ID: 3664568
    [No Abstract]   [Full Text] [Related]  

  • 20. Why measurement of apoB helps in the diagnosis and treatment of atherogenic dyslipoproteinemias.
    Sniderman A
    Can J Cardiol; 1991 May; 7(4):VII-VIII. PubMed ID: 2070282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.